Clinical REmission in peripheral SPondyloArthritis (CRESPA): Golimumab Effective for Early Peripheral Spondyloarthritis
First results from the CRESPA trial show…
medscape.com
CRESPA: Drug-Free Remission Achieved in Early Peripheral SpA
More than half of patients with early peripheral spondyloarthritis stopped treatment after remission
medpagetoday.com
Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study
Objective To evaluate the efficacy and safety of…
ard.bmj.com
Pre-Existing Psoriasis Is Predictive for Clinical Relapse after Drug-Free Remission Induced By Therapy with Golimumab in Early Peripheral Spondyloarthritis
Background/Purpose: The use of new treatment…
acrabstracts.org
